A review on drug repurposing for diabetes epidemic

Abstract

Repurposing of existing drugs to treat chronic, communicable and non-communicable diseases is becoming progressively important since it uses existing drug molecules or failed compounds by utilizing the available data. It uses several approaches, potentially decreasing the total development cost and shorter development timeframes. The traditional search for drugs for the treatment of diseases is a slow process, where significant expenses of new drug research and development are involved. This review discusses the drugs that are being approved for diabetes epidemic using drug repurposing approaches, as well as the challenges and future perspective.